Chemoinformaics analysis of 3-Methyl-3,4-divinylcyclohexene
| Molecular Weight | 148.249 | nRot | 2 |
| Heavy Atom Molecular Weight | 132.121 | nRig | 22 |
| Exact Molecular Weight | 148.125 | nRing | 1 |
| Solubility: LogS | -3.538 | nHRing | 0 |
| Solubility: LogP | 1.307 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 29.0387 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.628 |
| Synth | 3.778 |
| Natural Product Likeliness | 1.219 |
| NR-PPAR-gamma | 0.096 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.015 |
| HIA | 0.005 |
| CACO-2 | -5.438 |
| MDCK | 0.0000459 |
| BBB | 0.069 |
| PPB | 0.940985 |
| VDSS | 0.932 |
| FU | 0.0510225 |
| CYP1A2-inh | 0.022 |
| CYP1A2-sub | 0.953 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.928 |
| CYP2c9-inh | 0.009 |
| CYP2c9-sub | 0.726 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.235 |
| CYP3a4-inh | 0.136 |
| CYP3a4-sub | 0.872 |
| CL | 6.454 |
| T12 | 0.427 |
| hERG | 0.015 |
| Ames | 0.008 |
| ROA | 0.133 |
| SkinSen | 0.029 |
| Carcinogencity | 0.162 |
| EI | 0.009 |
| Respiratory | 0.208 |
| NR-Aromatase | 0.075 |
| Antiviral | No |
| Prediction | 0.848856 |